Synthesis and In Vitro Testing of YVO4:Eu3+@silica-NH-GDA-IgG Bio-Nano Complexes for Labelling MCF-7 Breast Cancer Cells

Molecules. 2022 Dec 29;28(1):280. doi: 10.3390/molecules28010280.

Abstract

We present a visual tool and facile method to detect MCF-7 breast cancer cells by using YVO4:Eu3+@silica-NH-GDA-IgG bio-nanocomplexes. To obtain these complexes, YVO4:Eu3+ nanoparticles with a uniform size of 10-25 nm have been prepared firstly by the hydrothermal process, followed by surface functionalization to be bio-compatible and conjugated with cancer cells. The YVO4:Eu3+@silica-NH-GDA-IgG nanoparticles exhibited an enhanced red emission at 618 nm under an excitation wavelength of 355 nm and were strongly coupled with MCF-7 breast cancer cells via biological conjugation. These bio-nanocomplexes showed a superior sensitiveness for MCF-7 cancer cell labelling with a detection percentage as high as 82%, while no HEK-293A healthy cells were probed under the same conditions of in vitro experiments. In addition, the detection percentage of MCF-7 breast cancer cells increased significantly via the functionalization and conjugation of YVO4:Eu3+ nanoparticles. The experimental results demonstrated that the YVO4:Eu3+@silica-NH-GDA-IgG bio-nanocomplexes can be used as a promising labelling agent for biomedical imaging and diagnostics.

Keywords: YVO4:Eu3+; bio-nanocomplexes; cancer cell labelling; labelling; nanoparticles.

MeSH terms

  • Breast Neoplasms*
  • Female
  • Humans
  • Immunoglobulin G
  • In Vitro Techniques
  • MCF-7 Cells
  • Silicon Dioxide*

Substances

  • Silicon Dioxide
  • Immunoglobulin G

Grants and funding

This research was funded by Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 103.03-2017.66.